お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は大腸がん市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは大腸がんの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の大腸がん市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは大腸がんのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に大腸がん市場を分類しています。本研究に含まれる主な企業は：Roche、Debiopharm、Merck Kgaa、Vaccinogen、Aeterna Zentaris、Keryx、Spectrum Pharmaceuticals、Mologen、Amgen、Bayer Healthcare

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Chemotherapy
    Targeted therapy
    Immunotherapy

用途別の市場セグメント：
    Early Colorectal Cancer
    Midterm Colorectal Cancer
    Late Colorectal Cancer

本レポートの詳細内容
世界の大腸がん市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、大腸がんタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の大腸がん収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の大腸がん市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、大腸がん市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

大腸がんのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：大腸がんのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：大腸がんの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章大腸がん企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：大腸がんの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：大腸がんの主要企業の概要を提供し、製品の説明と仕様、大腸がんの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).

Market Analysis and Insights: Global Colorectal Cancer Market
The global Colorectal Cancer market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.

Report Covers:
This report presents an overview of global market for Colorectal Cancer market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Colorectal Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Colorectal Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Colorectal Cancer revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Colorectal Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Colorectal Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, Debiopharm, Merck Kgaa, Vaccinogen, Aeterna Zentaris, Keryx, Spectrum Pharmaceuticals, Mologen and Amgen, etc.

Market Segmentation
By Company
    Roche
    Debiopharm
    Merck Kgaa
    Vaccinogen
    Aeterna Zentaris
    Keryx
    Spectrum Pharmaceuticals
    Mologen
    Amgen
    Bayer Healthcare

Segment by Type
    Chemotherapy
    Targeted therapy
    Immunotherapy

Segment by Application
    Early Colorectal Cancer
    Midterm Colorectal Cancer
    Late Colorectal Cancer

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Colorectal Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colorectal Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Colorectal Cancer Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Targeted therapy
    Table 4. Key Players of Immunotherapy
    Table 5. Global Colorectal Cancer Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Colorectal Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Colorectal Cancer Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Colorectal Cancer Market Share by Region (2019-2024)
    Table 9. Global Colorectal Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Colorectal Cancer Market Share by Region (2025-2030)
    Table 11. Colorectal Cancer Market Trends
    Table 12. Colorectal Cancer Market Drivers
    Table 13. Colorectal Cancer Market Challenges
    Table 14. Colorectal Cancer Market Restraints
    Table 15. Global Colorectal Cancer Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Colorectal Cancer Revenue Share by Players (2019-2024)
    Table 17. Global Top Colorectal Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer as of 2023)
    Table 18. Global Colorectal Cancer Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Colorectal Cancer Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Colorectal Cancer, Headquarters and Area Served
    Table 21. Global Key Players of Colorectal Cancer, Product and Application
    Table 22. Global Key Players of Colorectal Cancer, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Colorectal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Colorectal Cancer Revenue Market Share by Type (2019-2024)
    Table 26. Global Colorectal Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Colorectal Cancer Revenue Market Share by Type (2025-2030)
    Table 28. Global Colorectal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Colorectal Cancer Revenue Share by Application (2019-2024)
    Table 30. Global Colorectal Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Colorectal Cancer Revenue Share by Application (2025-2030)
    Table 32. North America Colorectal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Colorectal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Colorectal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Colorectal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Colorectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Colorectal Cancer Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Colorectal Cancer Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Colorectal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Colorectal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Colorectal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Colorectal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Colorectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Colorectal Cancer Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Colorectal Cancer Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Colorectal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Colorectal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Colorectal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Colorectal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Colorectal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Colorectal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Colorectal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Colorectal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Colorectal Cancer Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Colorectal Cancer Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Colorectal Cancer Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Colorectal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Colorectal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Colorectal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Colorectal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Colorectal Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Colorectal Cancer Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Colorectal Cancer Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche Colorectal Cancer Product
    Table 67. Roche Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 68. Roche Recent Developments
    Table 69. Debiopharm Company Details
    Table 70. Debiopharm Business Overview
    Table 71. Debiopharm Colorectal Cancer Product
    Table 72. Debiopharm Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 73. Debiopharm Recent Developments
    Table 74. Merck Kgaa Company Details
    Table 75. Merck Kgaa Business Overview
    Table 76. Merck Kgaa Colorectal Cancer Product
    Table 77. Merck Kgaa Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 78. Merck Kgaa Recent Developments
    Table 79. Vaccinogen Company Details
    Table 80. Vaccinogen Business Overview
    Table 81. Vaccinogen Colorectal Cancer Product
    Table 82. Vaccinogen Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 83. Vaccinogen Recent Developments
    Table 84. Aeterna Zentaris Company Details
    Table 85. Aeterna Zentaris Business Overview
    Table 86. Aeterna Zentaris Colorectal Cancer Product
    Table 87. Aeterna Zentaris Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 88. Aeterna Zentaris Recent Developments
    Table 89. Keryx Company Details
    Table 90. Keryx Business Overview
    Table 91. Keryx Colorectal Cancer Product
    Table 92. Keryx Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 93. Keryx Recent Developments
    Table 94. Spectrum Pharmaceuticals Company Details
    Table 95. Spectrum Pharmaceuticals Business Overview
    Table 96. Spectrum Pharmaceuticals Colorectal Cancer Product
    Table 97. Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 98. Spectrum Pharmaceuticals Recent Developments
    Table 99. Mologen Company Details
    Table 100. Mologen Business Overview
    Table 101. Mologen Colorectal Cancer Product
    Table 102. Mologen Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 103. Mologen Recent Developments
    Table 104. Amgen Company Details
    Table 105. Amgen Business Overview
    Table 106. Amgen Colorectal Cancer Product
    Table 107. Amgen Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 108. Amgen Recent Developments
    Table 109. Bayer Healthcare Company Details
    Table 110. Bayer Healthcare Business Overview
    Table 111. Bayer Healthcare Colorectal Cancer Product
    Table 112. Bayer Healthcare Revenue in Colorectal Cancer Business (2019-2024) & (US$ Million)
    Table 113. Bayer Healthcare Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Colorectal Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Colorectal Cancer Market Share by Type: 2023 VS 2030
    Figure 3. Chemotherapy Features
    Figure 4. Targeted therapy Features
    Figure 5. Immunotherapy Features
    Figure 6. Global Colorectal Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Colorectal Cancer Market Share by Application: 2023 VS 2030
    Figure 8. Early Colorectal Cancer Case Studies
    Figure 9. Midterm Colorectal Cancer Case Studies
    Figure 10. Late Colorectal Cancer Case Studies
    Figure 11. Colorectal Cancer Report Years Considered
    Figure 12. Global Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Colorectal Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Colorectal Cancer Market Share by Region: 2023 VS 2030
    Figure 15. Global Colorectal Cancer Market Share by Players in 2023
    Figure 16. Global Top Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Colorectal Cancer Revenue in 2023
    Figure 18. North America Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Colorectal Cancer Market Share by Type (2019-2030)
    Figure 20. North America Colorectal Cancer Market Share by Application (2019-2030)
    Figure 21. North America Colorectal Cancer Market Share by Country (2019-2030)
    Figure 22. United States Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Colorectal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Colorectal Cancer Market Share by Type (2019-2030)
    Figure 26. Europe Colorectal Cancer Market Share by Application (2019-2030)
    Figure 27. Europe Colorectal Cancer Market Share by Country (2019-2030)
    Figure 28. Germany Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Colorectal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Colorectal Cancer Market Share by Type (2019-2030)
    Figure 36. China Colorectal Cancer Market Share by Application (2019-2030)
    Figure 37. Asia Colorectal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Colorectal Cancer Market Share by Type (2019-2030)
    Figure 39. Asia Colorectal Cancer Market Share by Application (2019-2030)
    Figure 40. Asia Colorectal Cancer Market Share by Region (2019-2030)
    Figure 41. Japan Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Colorectal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Colorectal Cancer Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Colorectal Cancer Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Colorectal Cancer Market Share by Country (2019-2030)
    Figure 51. Brazil Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Colorectal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Roche Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 58. Debiopharm Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 59. Merck Kgaa Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 60. Vaccinogen Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 61. Aeterna Zentaris Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 62. Keryx Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 63. Spectrum Pharmaceuticals Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 64. Mologen Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 65. Amgen Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 66. Bayer Healthcare Revenue Growth Rate in Colorectal Cancer Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed